Evidence map›Paper›PMID 36873575›Full record

ReviewSaudi journal of biological sciences2023

Evaluation of the antibacterial activity of Weissella confusa K3 cell-free supernatant against extended-spectrum βeta lactamase (ESBL) producing uropathogenic Escherichia coli U60.

Rasha M El-Mekkawy, Noura E Hamour, Wesam A Hassanein, Ayman A Allam

Open access · hybridAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Saudi journal of biological sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Observational
  6. Foods (Basel, Switzerland) · 2024
    Article
  7. TheFrontiers in microbiology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Rasha M El-MekkawyDepartment of Botany and Microbiology, Faculty of Science, Zagazig University, 44519, Egypt.
Noura E HamourDepartment of Botany and Microbiology, Faculty of Science, Zagazig University, 44519, Egypt.
Wesam A HassaneinDepartment of Botany and Microbiology, Faculty of Science, Zagazig University, 44519, Egypt.
Ayman A AllamDepartment of Medical Microbiology and Immunology, Faculty of Medicine, Zagazig University, Egypt.
Zagazig University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Different strategies have been approved for controlling extended-spectrum βeta lactamase (ESBL) producing uropathogenic bacteria. The antibacterial activity of Lactic acid bacteria (LAB) is an effective strategy due to its probiotic characteristics and beneficial effects on human health. The antibiotic susceptibility test, disk diffusion method, and double disc synergy test indicated that five enteric uropathogenic isolates were ESBL producers during the present study. They recorded diameters of inhibition zones as ≤ 18, ≤ 8, ≤ 19, and ≤ 8 mm against cefotaxime (CTX), ceftazidime (CAZ), aztreonam (ATM), and ceftriaxone (CRO). Genotypically,

Indexed as

Antibacterial activityAntibiotic resistanceECU60, Escherichia coli U60ESBL, extended-spectrum beta-lactamaseExtended-spectrum beta-lactamaseLAB, lactic acid bacteriaLactic acid bacteriaMHA, Mueller–Hinton agarMRD, Multidrug resistanceMRS, De Man, Rogosa, and SharpeUrinary tract infectionUTI, Urinary tract infectionU, Urine sampleWC K3, Weissella confusa K3

Identifiers

PMID36873575
PMCPMC9974428
OpenAlexW4321439175

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.